600873 梅花生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)19.71319.07222.98536.43224.316
总资产报酬率 ROA (%)12.14911.67013.35219.38112.019
投入资产回报率 ROIC (%)13.84213.28415.31822.41313.947

边际利润分析
销售毛利率 (%)21.26420.07519.68125.13319.406
营业利润率 (%)14.59713.92713.73718.47112.703
息税前利润/营业总收入 (%)18.82212.89313.29118.74413.271
净利润/营业总收入 (%)16.60710.93111.45915.77210.526

收益指标分析
经营活动净收益/利润总额(%)69.15795.73796.74696.00891.576
价值变动净收益/利润总额(%)1.9591.344-0.8191.1079.915
营业外收支净额/利润总额(%)22.762-4.234-2.424-0.143-1.596

偿债能力分析
流动比率 (X)1.2901.1961.4561.4861.354
速动比率 (X)1.0050.8301.0090.8760.819
资产负债率 (%)37.99538.78538.84044.81349.128
带息债务/全部投入资本 (%)27.68927.98328.28733.07638.454
股东权益/带息债务 (%)254.708249.687245.454193.365152.614
股东权益/负债合计 (%)163.190157.830157.469123.151103.550
利息保障倍数 (X)-245.697-27.563-110.38262.43317.296

营运能力分析
应收账款周转天数 (天)8.5858.8256.3674.0044.181
存货周转天数 (天)46.10850.71056.43760.76350.502